Lithuanian Lung Cancer Implementation Guide
0.0.1 - ci-build
Lithuanian Lung Cancer Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-lung/ and changes regularly. See the Directory of published versions
Dabartiniam puslapiui nėra vertimo puslapio, todėl jis pateiktas numatytąja kalba
Turinys:
Šiame puslapyje pateikiamas FHIR artefaktų, apibrėžtų šiame diegimo vadove, sąrašas.
Jie apibrėžia formas, kurias naudoja sistemos, atitinkančios šį įgyvendinimo vadovą, duomenims rinkti ar pateikti galutiniams vartotojams.
| Questionnaire: LDCT ESPBI Form (LT Lung) |
Structured data-capture form for low-dose chest computed tomography (LDCT) reporting based on ADP Table 7.1 (MDKT dataset). |
| Questionnaire: Pre-LDCT Questionnaire (LT Lung) |
Structured data-capture form for the pre-examination questionnaire before LDCT screening, based on ADP Table 7.2. Captures functional status, prior examinations, anthropometrics, smoking history, and current diagnoses. |
Jie apibrėžia FHIR resursų apribojimus sistemoms, atitinkančioms šį įgyvendinimo vadovą.
| Adrenal Lesion (LT Lung) |
Adrenal gland lesion incidental finding detected during LDCT screening, per ADP dataset section 1.2.2.2 item 14. Captures laterality, largest dimension, and density in Hounsfield units (HV). |
| Incidental Finding (LT Lung) |
Significant incidental finding detected during low-dose chest computed tomography (LDCT) screening. Covers both pulmonary incidental findings (emphysema, bronchiectasis, pleural changes, etc.) and extra-pulmonary findings (coronary calcification, aortic aneurysm, mediastinal mass, etc.) as defined in the MDKT dataset sections 1.2.2.1 and 1.2.2.2. |
| Kidney Lesion (LT Lung) |
Kidney lesion incidental finding detected during LDCT screening. Significant lesions are 1 cm or larger, or smaller ones where malignancy cannot be excluded, per ADP dataset section 1.2.2.2 item 12. Calcified density can co-occur with cystic, solid, or complex. |
| LUNG-RADS Assessment (LT Lung) |
LUNG-RADS assessment category assigned to a low-dose chest CT (LDCT) screening examination in the Lithuanian lung cancer early diagnosis programme. The observation represents the final radiological assessment that determines the follow-up recommendation and screening pathway. SNOMED CT code 1362105002 is used for the observable concept 'Lung Imaging Reporting and Data System category (observable entity)'. The actual assessment value is represented using a local code system for the main category values 0, 1, 2, 3, 4A, 4B, and 4X, because separate SNOMED CT codes for those category values are not provided in the source dataset. The optional S modifier is represented as a component. |
| Lung Composition (LT Lung) |
Lung-specific imaging composition extending the base imaging composition with lung-specific constraints on findings, impression, and recommendation sections. Designed for use in the Lithuanian lung cancer prevention programme LDCT screening. |
| Lung LDCT Report (LT Lung) |
Overall lung LDCT diagnostic report covering the low-dose chest computed tomography screening pathway. Wraps a LungCompositionLtLung and aggregates structured results including LUNG-RADS assessments, pulmonary nodule observations, incidental findings, and follow-up recommendations. |
| Lung Screening Recommendation (LT Lung) |
Recommendation for follow-up or referral after low-dose chest CT (LDCT) screening examination in the Lithuanian lung cancer early diagnosis programme. This observation captures the recommended next action following the final LUNG-RADS assessment. SNOMED CT code 424900004 is used for the observation concept 'Recommendation - action (qualifier value)'. The actual recommendation value is represented using a local code system, because the source dataset provides programme-specific recommendation options. |
| Mediastinal Mass (LT Lung) |
Mediastinal mass incidental finding detected during LDCT screening. Multiple masses can be recorded as separate observation instances. At least one of size, changed density, or calcification should be documented per ADP dataset section 1.2.2.2 item 4. |
| Pulmonary Nodule (LT Lung) |
Pulmonary nodule identified on low-dose chest CT (LDCT) in the Lithuanian lung cancer early diagnosis programme. One observation represents one pulmonary nodule (Židinys). Multiple nodules are represented as multiple Observation instances. The observation captures the nodule type, localisation, CT slice number, morphological features, measurements, and optional note. |
Jie apibrėžia kodų rinkinius, naudojamus sistemų, atitinkančių šį įgyvendinimo vadovą.
| Adrenal Laterality |
Adrenal gland laterality for lesion location (ADP 1.2.2.2 item 14). |
| Consolidation Interpretation |
Interpretation subtypes for lung consolidation detected during LDCT screening: likely inflammatory or suspected malignant (ADP 1.2.2.1 item 9). |
| Coronary Calcification Visual Score |
Visual semi-quantitative scoring of coronary artery calcification during LDCT screening (ADP 1.2.2.2 item 1). |
| Finding Density |
Radiologic density or texture types of a lesion detected during LDCT screening. |
| Finding Multiplicity |
Number of occurrences of a finding: singular or multiple. |
| Finding Quantity |
Amount of a finding: small, medium, or large. Used for pleural fluid, pericardial effusion, and similar quantifiable incidental findings. |
| Incidental Finding |
Significant incidental findings in the chest and abdominal areas detected during low-dose chest computed tomography (LDCT) screening. |
| Kidney Laterality |
Kidney laterality for lesion location. |
| Kidney Lesion Density |
Density types for kidney lesions detected during LDCT screening. Calcified can co-occur with cystic, solid, or complex. |
| LUNG-RADS Assessment Category |
Allowed primary LUNG-RADS assessment categories used in the Lithuanian lung cancer early diagnosis programme. |
| LUNG-RADS Assessment Modifier Codes |
Allowed LUNG-RADS assessment modifier codes used in the Lithuanian lung cancer early diagnosis programme. |
| Lung Lobe |
Allowed lung lobe body structure codes for localisation of pulmonary nodules in the Lithuanian lung cancer early diagnosis programme. |
| Lung Screening Recommendation Value Set |
Allowed recommendation codes used in the Lithuanian lung cancer early diagnosis programme for follow-up and referral decisions. |
| Lymph Node Location |
Locations of lymphadenopathy detected during LDCT screening. |
| Pulmonary Nodule Morphology Features |
Allowed morphology characteristics for pulmonary nodules in the Lithuanian lung cancer early diagnosis programme. |
| Pulmonary Nodule Type |
Allowed pulmonary nodule type values used in the Lithuanian lung cancer early diagnosis programme. |
Jie apibrėžia naujas kodų sistemas, naudojamas sistemų, atitinkančių šį įgyvendinimo vadovą.
| LUNG-RADS Assessment Categories |
Main LUNG-RADS assessment categories used in the Lithuanian lung cancer early diagnosis programme. These codes represent the primary final assessment category assigned to the low-dose chest CT screening examination. |
| LUNG-RADS Assessment Modifier |
Additional modifier used together with the main LUNG-RADS assessment category in the Lithuanian lung cancer early diagnosis programme. The modifier S indicates clinically significant incidental findings that contribute to the overall assessment string, for example 0S or 4AS. |
| Lung Screening Recommendation Codes |
Recommendation codes used in the Lithuanian lung cancer early diagnosis programme for follow-up and referral actions after LUNG-RADS assessment. These codes represent the recommended next clinical action based on the radiological conclusion and programme rules. |
| Lung questionnaire answer options |
Illustrative answer option codes for ESPBI questionnaire forms used in the Lithuanian lung cancer prevention programme. |
| Pulmonary Nodule Observation Component Codes |
Local component codes for pulmonary nodule observation elements used in the Lithuanian lung cancer early diagnosis programme when no suitable SNOMED CT code is available in the source dataset. |
| Pulmonary Nodule Type Local Codes |
Local codes for pulmonary nodule types used in the Lithuanian lung cancer early diagnosis programme when no suitable SNOMED CT code is available in the source dataset. |
| SNOMED CT Extension Codes |
Local extension codes used in the Lithuanian lung cancer early diagnosis programme when no suitable SNOMED CT code is available. These codes extend SNOMED CT concepts with local granularity required by the ADP dataset. |
Tai yra pavyzdiniai egzemplioriai, kurie parodo, kaip gali atrodyti duomenys, sukurti ir sunaudoti sistemų, atitinkančių šį įgyvendinimo vadovą.
| Composition: LDCT Screening Report (example) |
LDCT screening composition with solid nodule in right upper lobe, moderate coronary calcification, LUNG-RADS 4A impression, and 3-month follow-up recommendation. |
| DiagnosticReport: LDCT Screening Report (example) |
LDCT screening report aggregating LUNG-RADS 4A assessment, solid nodule in right upper lobe, moderate coronary calcification, and 3-month follow-up recommendation. |
| ImagingStudy: LDCT Screening (example) |
Low-dose chest CT imaging study acquired during lung cancer screening. |
| Observation: Bilateral Pleural Effusion (example) |
Incidental finding of bilateral pleural effusion detected during LDCT screening. |
| Observation: Coronary Artery Calcification, Moderate (example) |
Incidental finding of moderate coronary artery calcification detected during LDCT screening. |
| Observation: Ground Glass Nodule – Right Middle Lobe, 9 mm (example) |
Ground glass pulmonary nodule in the right middle lobe (9 mm mean diameter, 320 mm3) with subpleural tissue abnormality detected during LDCT screening. |
| Observation: LUNG-RADS 4A with S modifier (example) |
Final LUNG-RADS category 4A assessment with S modifier indicating a suspicious pulmonary lesion and a significant incidental extrapulmonary finding. |
| Observation: LUNG-RADS Category 4A (example) |
Final LUNG-RADS category 4A assessment indicating a suspicious pulmonary lesion requiring short-term follow-up. |
| Observation: Lung Consolidation, Likely Inflammatory (example) |
Incidental finding of lung consolidation with structured interpretation indicating likely inflammatory origin. |
| Observation: Lung screening recommendation - 3 month (example) |
Follow-up LDCT recommended after 3 months based on LUNG-RADS 4A assessment. |
| Observation: Lung screening recommendation - pulmonologist consultation (example) |
Referral to pulmonologist consultation in an oncology cluster institution for further evaluation of suspicious findings. |
| Observation: Mediastinal Lymphadenopathy, Multiple, Bilateral (example) |
Incidental finding of multiple bilateral mediastinal lymphadenopathy detected during LDCT screening. |
| Observation: Mediastinal Mass with Abnormal Density (example) |
Incidental finding of a 32 mm mediastinal mass with complex density detected during LDCT screening. |
| Observation: Part-Solid Nodule – Left Upper Lobe, 18 mm (example) |
Part-solid pulmonary nodule in the left upper lobe (18 mm total, 7 mm solid component) with microlobulated margin and subpleural tissue abnormality detected during LDCT screening. |
| Observation: Pulmonary Emphysema, Severe (example) |
Incidental finding of severe (>50%) pulmonary emphysema detected during LDCT screening. |
| Observation: Right Adrenal Lesion, 18mm, 12 HV (example) |
Incidental finding of a right adrenal gland lesion detected during LDCT screening with size and density in Hounsfield units. |
| Observation: Solid Nodule – Right Upper Lobe, 11 mm (example) |
Solid pulmonary nodule in the right upper lobe (11 mm mean diameter, 610 mm3) with spiculated margin detected during LDCT screening. |
| Organization: Santaros Klinikos (example) |
Healthcare institution where the LDCT screening examination was performed. |
| Patient: Male (example) |
Male patient participating in the lung cancer screening programme. |
| Practitioner: Radiologist (example) |
Radiologist practitioner performing LDCT screening interpretation. |
| PractitionerRole: Radiologist (example) |
Radiologist practitioner role responsible for LDCT screening interpretation and reporting. |
| Procedure: LDCT Screening (example) |
Low-dose chest CT procedure performed as part of the lung cancer screening programme. |
| QuestionnaireResponse: LDCT ESPBI (example) |
LDCT screening example – solid nodule in right upper lobe, moderate coronary calcification, LUNG-RADS 4A. |
| QuestionnaireResponse: Pre-LDCT Questionnaire (example) |
Pre-LDCT screening questionnaire example – active smoker, 30 pack-years, height 178cm, weight 82kg. |